WHAT THIS PAPER ADDS When screening 70-year-old men for AAA, the prevalence was 2.3%, which is less than half the predicted. The attendance rate was 84.0% and smoking was the strongest risk factor for AAA. The total known prevalence in the population was 3.0%; thus almost 40% of the men with AAAs were already known from other means, hence questioning the benefit of screening 70-instead of 65-year-old men, since only men with unknown AAAs have anything to gain from screening.
INTRODUCTION
Ruptured abdominal aortic aneurysm (rAAA) is a common cause of death, especially among elderly men, with an overall mortality of at least 75%. 1 In Sweden, approximately 600 people die from this annually, comprising 1% of the total mortality among men older than 65 years of age.
1 A cost-effective method of reducing the mortality from rAAA by half is by screening 65-year-old men for AAAs and surveillance those found. 2 Aneurysm repair should be considered when the risk of rupture is greater than the risk of the surgical treatment, that is at an AAA diameter of approximately 5.5 cm. 3 Screening for AAA is now adopted around the world and is practically nationwide in, for example England, Scotland, and Sweden, and in the United States as part of the Medicare-programme. 4 However, in recent studies concerning 65-year-old men, a prevalence of 1.6e 1.7% has been found, which is only one-third of the 4.9% that has previously been estimated by using a meta-analysis of studies reporting the prevalence in specifically 65-yearold men. 4e7 As the prevalence of AAA seems to increase with age, there is an ongoing debate whether screening of men older than 65 years might increase the efficacy of screening. 5, 8, 9 The aims of the study were to determine the contemporary screening-detected prevalence of AAA among previously unscreened 70-year-old men and to define potential risk factors and their association to AAA.
METHODS
The study-population consisted of all men in Östergötland, Sweden, becoming 70 years old (born 1938e40) during 2008e2010. They had not previously been screened for AAA and they were identified through the National Population Registry, and with 2 weeks notice all, without any exclusion criteria, were invited to an ultrasound examination of the infrarenal aorta. If they were not able to attend the examination, they were urged to re-book by phone or Internet. One reminder was sent to those who did not attend or reply. The examination was free of charge but no travel expenses were reimbursed.
In order to increase the attendance rate we used a decentralized way of screening in that the examination was carried out at two of the three hospitals in the region and in addition at seven district health care centres. The examination was carried out by an experienced technician, using a portable ultrasound machine (GE Vivid i from General Electric Health Care, Waukesha, WI, USA) with a 4C-RS probe (1.8e6.0 MHz). All together nine dedicated technicians, working in pairs, specialized in ultrasound examinations of the peripheral arterial tree, performed the scans. Fasting was not demanded and the standard position was supine. If the aorta was difficult to visualize, other positions were used and/or the other technician tried to visualize the aorta. If the aorta still not could be visualized, the subject was invited for a new attempt, but now during fasting. Weight and height were also measured. Along with the invitation, an information leaflet concerning AAA was enfolded, as well as a Health Questionnaire to be completed prior to examination, in order to diminish recall bias. The questionnaire contained questions regarding heredity concerning AAA, smoking habits, current medication, and presence or absence of the following diseases: hypertension, hyperlipidaemia, diabetes mellitus, chronic obstructive pulmonary disease (COPD), renal disease, cerebrovascular disease (CVD), claudication, coronary heart disease (CHD) reflected as angina pectoris and/or myocardial infarction, rheumatic disease, and cancer. All these data were selfreported.
An AAA was defined as the infrarenal aortic diameter being !30 mm. The aorta was scanned with the probe in the transverse (horizontal) position and then in the sagittal (vertical) position. The greatest anteroposterior (AP) diameter of the aorta was measured according to the "leadingedge-to-leading-edge" principle. 10 From local databases men born 1938e40 with an already known AAA under surveillance were identified and excluded from the cohort, since our intention was to study men with screening-detected AAA. With aid of the Swedish Vascular Registry (Swedvasc, a nationwide register with a documented high validity) all men in our cohort who had already been treated for an AAA were identified and excluded for the same reason. 11, 12 The chi-square test with continuity correction was used for the univariate analysis, and when the validity of the chisquare test was in question (too small expected numbers in any cell of the 2 Â 2 table) the result was checked with the Fisher test. Univariate analyses for testing differences in continuous variables were made with a t test. Logistic regression was used for the multivariable analysis and variables with p < .1 from the univariate chi-square test entered into the multivariable logistic regression ("glm" in the R-package). 13, 14 The different risk factors and medications were entered as being present or absent in the logistic regression.
The relative risk of differences in body mass index (BMI) for the prevalence of AAA was calculated by exponentiation of the predicted log odds (from logistic regression) to odds, by transforming odds to probabilities, and finally the quotient of the probabilities of the two BMIs of interest.
The expected point prevalence for 70-year-old men was calculated by using data from previous studies concerning men !66 years of age by means of a multiple linear regression analysis ("lm" in the R-package) 13, 14 weighted for the number of men in each study used (Table 1) . 8,15e21 Calculations and statistical analyses were performed in the R-language from the R-Project for Statistical Computing 13 and Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) was used as a database.
The Regional Ethical Review Board in Linköping approved the study.
RESULTS
Altogether 5,623 men who reached 70 years old during the years 2008e2010 and were invited to screening. The attendance rate was 84.0%, and of the 4,721 that attended six men were excluded, three due to poor visibility on ultrasound examination and three because they already had a known AAA under surveillance. The final screening cohort was 4,715.
The mean aortic diameter was 19.7 mm: 93.4% of the men had an aortic diameter <25 mm and 4.3% had a diameter of 25e29 mm. Eleven (10.3%) of the 107 men with a screening-detected AAA had an aneurysm of >54 mm in diameter, thus requiring evaluation for surgical treatment. Of the 107 AAAs, the vast majority, 93 (87%), were <40 mm in diameter.
Thirteen men with a former known AAA did not attend screening and neither did 38 of the 48 men previously treated for an AAA/rAAA. Of the 10 who had been treated and who attended, one had developed a new AAA (32 mm in diameter) proximal to the graft. The screening-detected AAA prevalence was 2.3% (n ¼ 107). Adding the 48 men who already had been treated for an AAA/rAAA and the 16 men with non-screening-detected AAA to the screeningdetected AAAs, the total known prevalence was at least 3.0% (171/5623); therefore, 64 (37.4%) of the AAAs were already known or had been previously treated in this cohort.
In Table 2 the results from the univariate analysis testing for potential risk factors for AAA are shown. The most significant risk factors were "Current smoker", "CHD", and "Renal disease", all reaching p < .001. For those individuals who were "Ex smokers" the prevalence of AAA was 2.5% and for those who were "Current smokers" the prevalence was 5.5%, compared with 0.65% among those who had "Never smoked".
An increased BMI was found among the men with an AAA, p < .01, compared with those without (t test). From a logistic regression analysis on BMI and AAA, we found that two BMI steps, for example from 25 to 27 kg/m 2 , which in a man who is 1.77 m tall and weighs 83 kg is slightly more than 6 kg, increased the probability of having an AAA by 19.0% (relative risk). Ten risk factors (excluding medication) had p < .1 in the univariate analysis and these were tested in a multivariable logistic regression analysis (Table 3) . Of the 4,715 men in the screening cohort, 3,872 had complete registrations regarding these risk factors. The two risk factors "Ex smoker" and "Current smoker" remained the strongest risk factors, OR 3.3 (95% CI 1.7e6.6) and 8.9 (95% CI 4.2e18.6) respectively, p < .001 for both. Also the risk factors "Renal disease", COPD, and CVD remained associated with AAA.
When we included body mass index (BMI) in the multivariable analysis, no major changes with respect to the association between AAA and the other risk factors occurred. We did not include BMI in the final multivariable analysis, since overweight in itself is not a disease, as long as BMI is <30. Instead, quite small changes in BMI were associated with changes in risk for an AAA.
DISCUSSION
The main finding of this screening study, comprising almost 5,000 Swedish 70-year-old men, was the low prevalence of AAA (2.3%).
By using data from previous studies concerning men !66 years of age, we calculated the expected AAA-prevalence for 70-year-old men (Fig. 1) to 5.7% (r ¼ 0.91 and p ¼ .03), and the prevalence in our screening-study of 2.3% was significantly lower (p ¼ .014), less than half the predicted for this age.
When including men with already known AAAs, the total known prevalence was at least 3.0%, thus almost 40% of all the men with AAAs were already treated or under surveillance. However, only subjects with undetected AAAs have anything to gain from a screening programme.
Smoking is the most important known risk factor for AAA and the excess prevalence for AAA associated with smoking accounts for 75% of all AAAs !4 cm. 8 Smoking correlates with increased expansion of AAA, increased risk of rupture, poorer long-term survival, and quitting smoking may reduce growth rate of small AAAs. 22e24 We also found strong associations between the risk factors "Ex smoker" and AAA, and "Current smoker" and AAA, odds ratio being 3.3 and 8.9 respectively.
Approximately 20% of AAA patients have previously been shown to have a first-degree relative with the disease. 8,25e27 In our study, having a first-degree relative with AAA was not a significant predisposing factor for AAA. The explanation for this might be that in Sweden many AAA patients are urged to encourage their first-degree relatives to have their aorta examined. This might also be one reason for the high incidental finding of AAA.
In the UK Endovascular AAA Repair 1 (EVAR 1), the Dutch Randomized Endovascular Aneurysm Repair (DREAM), and the Open Versus Endovascular Repair (OVER) trials, a positive correlation between AAA and cancer was found, and mortality due to cancer was considerably higher than AAArelated or cardiovascular mortality. 28e30 The reason for the cancereAAA correlation is probably due to the joint relation with smoking.
To our surprise, we found a tendency to a lower AAA prevalence among men with cancer, OR 0.4 (95% CI 0.1e 1.1), p ¼ .079. One explanation might be that those individuals who are diagnosed with cancer, almost always are subjected to a computed tomography (CT) or magnetic resonance imaging (MRI) scan, which means that any existing AAA is discovered and thus would be found in the group of already discovered AAA prior to screening. It is unknown whether the 64 patients with an already known Table 3 . Multivariable logistic regression analysis of variables associated with the presence of an abdominal aortic aneurysm.
Risk factor
Odds ratio Confidence interval (95%) Table 2 , were included in the multivariable analysis. The number of complete observations used in the analysis is 3872 (of 4,715 in the screening cohort). AAA ¼ aortic abdominal aneurysm; rAA ¼ ruptured aortic aneurysm; COPD ¼ chronic obstructive pulmonary disease; CVD ¼ cerebrovascular disease; CHD ¼ coronary heart disease. Figure 1 . The predicted prevalence for 70-year-old men was 5.7%, using data from previous studies (filled circles, from left to right: ADAM, 8 Lindholt, 15 MASS, 16 (below line), Simoni 17 (above line), Norman, 18 Bengtsson et al., 19, 20 and Ljungberg et al. 21 ) concerning men !66 years of age (Table 1) , weighted for the number of men in each study, r ¼ .91, p ¼ .003. The prevalence in this study was 2.3% (unfilled circle), thus less than half the predicted, p ¼ .0014. AAA in our cohort actually had a higher cancer prevalence than the study population, since we did not have the ethical permission to review case notes of individual patients.
We found an association between increased BMI and having an AAA. Being overweight increases the risk for AAA although the effects are small compared with age, gender, and smoking. 26, 31, 32 Diabetes mellitus (DM) has in prior works been shown to be a protector against AAA. 8, 33 In our cohort of 70-year-old men, the AAA prevalence was not lower among diabetics. One reason for this might be that with increasing age, the protective effect of DM decreases as other factors contributing to the development of AAA, for example atherosclerosis, become more dominant.
The lower than predicted AAA prevalence reported in this study is in line with the prevalence seen among 65-year-old men in other contemporary studies. 5,6,9,34e36 The steep decrease in daily smoking in Sweden (Fig. 2 ) and in the rest of the Western world might be one cause for the decline in AAA prevalence, since smoking is the strongest risk factor for having an AAA. 37 Thus, in countries with similar development regarding smoking habits as in Sweden, the prevalence of AAA among 70-year-old men may be expected to be as low as in this study.
The use of lipid-lowering agents, treatment with angiotensin-converting enzyme (ACE) inhibitors and overall better regulation of hypertension have also been suggested as contributors to the declining prevalence.
38e40 No associations pointing in this direction were found in this cohort; on the contrary, the use of lipid-lowering agents, thrombocyte inhibitors, and beta-receptor blockers were already significantly more common among those with a screeningdetected AAA, indicating an already known greater cardiovascular morbidity. 26 The men with an AAA were also significantly more affected by renal disease, COPD, and CVD; however, and a bit surprising, diseases normally associated with atherosclerosis and smoking, for example claudication, CHD, and hyperlipidaemia, failed to prove fully significant in our study. Most likely the diseases associated with smoking are also associated with each other and therefore may fail to show up in the multivariable analysis as independent risk factors for AAA. Thus, if patients with smoking-associated diseases other than AAA, use of lipidlowering agents, thrombocyte inhibitors, and betareceptor blockers will also be associated with a higher prevalence of AAA.
The prevalence of AAA among the 70-year-old men in this study was higher than the 1.6e1.7% rate reported from screening 65-year-old men. 4e6 This might be considered a reason to raise the age threshold for screening. However, almost 40% of all known AAAs in the population had already been discovered, contradicting this notion. 5, 9 Another possible explanation for the high rate of incidentally found AAAs (besides screening of relatives and CT/MRI scans among cancer patients, as discussed above) might be the trend, at least in Sweden, towards performing more advanced radiological examinations also in the acute setting, such as CT-scans, where most AAAs are easily seen.
We experienced a high attendance rate e 84%. The fact that we utilized a partly decentralized screening method and that the examination was free of charge might have contributed to this. Decreasing attendance rate is associated with increasing prevalence of AAA and social deprivation. 41 However, despite the high attendance rate in this study, the screening-detected prevalence was lower than ever reported previously for this age. Assuming that the prevalence among those individuals who did not attend screening is the same as in the rest of this age group, the estimated total AAA prevalence in the population would be 2.3% þ 64/5,623 ¼ 3.4%.
In conclusion, when screening 4,715 70-year-old men in Östergötland, Sweden, for AAA, we found the lowest ever reported prevalence for this age, 2.3%, less than half the predicted prevalence. When including those men who already had been treated for an AAA or were under surveillance, the total known prevalence was at least 3.0%; thus almost 40% of the AAAs were incidentally found. The most important risk factor for AAA was smoking.
The present study does not lend support to the notion that screening at an age higher than 65 years would result Figure 2 . Percentage of Swedish men, 16e84 years old, smoking on a daily basis, 1980e2005. From Statistics Sweden (SCB). 37 in detection of substantially more AAAs, since such a large part of the AAAs are already detected by means other than screening.
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